GlassScriptPhysician profile
Brandy Jo Centers
NPI 1225401573
$16,511.78
in general payments reported to CMS, 2019-2025
60 companies · $2,883 in 2025
The $2,883 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,435 · 2022: $3,648 · 2023: $3,573 · 2024: $2,973 · 2025: $2,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,328 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,328.26 |
| Education | $100.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,453.13 | 2021-2025 | |
| Ucb, INC. | $1,428.02 | 2022-2025 | Briviact, Fintepla, Zilbrysq |
| Biohaven Pharmaceuticals, INC. | $1,006.45 | 2021 | |
| Pfizer INC. | $917.43 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $793.13 | 2021-2025 | Ingrezza, Ongentys |
| Amgen INC. | $709.75 | 2021-2025 | Aimovig |
| Teva Pharmaceuticals USA, INC. | $643.71 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Eisai INC. | $428.55 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $414.59 | 2021-2025 | |
| Lilly USA, LLC | $393.86 | 2021-2024 | Emgality, Amyvid, Reyvow |
| Lundbeck LLC | $366.36 | 2022-2025 | Vyepti |
| Impel Pharmaceuticals INC. | $343.24 | 2022-2023 | Trudhesa |
| Alexion Pharmaceuticals, INC. | $331.62 | 2021-2025 | Ultomiris |
| Biohaven Pharmaceutical Holding Company LTD. | $264.97 | 2022 | |
| Genzyme Corporation | $264.03 | 2021-2022 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $263.46 | 2022-2023 | Gocovri |
| Otsuka America Pharmaceutical, INC. | $263.37 | 2023-2025 | Rexulti, Nuedexta |
| Biogen, INC. | $253.78 | 2021 | |
| Csl Behring | $247.17 | 2022-2025 | Hizentra |
| Celgene Corporation | $185.29 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $181.98 | 2022-2025 | Hyqvia |
| Jazz Pharmaceuticals INC. | $176.24 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $174.08 | 2021-2025 | Rytary, Crexont |
| Allergan, INC. | $170.61 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $169.69 | 2021-2022 | |
| Catalyst Pharmaceuticals, INC. | $164.53 | 2023-2025 | Fycompa |
| Tg Therapeutics, INC. | $162.80 | 2025 | |
| Argenx US, INC. | $154.58 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Upsher-Smith Laboratories LLC | $152.34 | 2021-2022 | |
| Tanabe Pharma America, INC. | $143.83 | 2023-2025 | Radicava |
| Acorda Therapeutics, INC | $141.44 | 2022-2024 | Inbrija |
| Sumitomo Pharma America, INC. | $139.62 | 2023-2024 | Aptiom |
| Insightec,INC | $127.61 | 2025 | Exablate |
| Sk Life Science, INC. | $118.74 | 2021-2025 | |
| Emd Serono, INC. | $99.05 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $95.46 | 2021-2025 | Nuplazid |
| Scilex Pharmaceuticals INC. | $89.85 | 2023-2024 | Ztlido |
| Neurelis, INC. | $81.75 | 2021-2024 | Valtoco |
| Janssen Pharmaceuticals, INC | $80.96 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $72.06 | 2021-2022 | |
| Genentech USA, INC. | $65.12 | 2025 | Ocrevus Zunovo |
| Avion Pharmaceuticals | $62.14 | 2022-2023 | Dhivy |
| Horizon Therapeutics Plc | $61.60 | 2021 | |
| Merz Pharmaceuticals, LLC | $60.92 | 2022-2024 | Xeomin |
| Boston Scientific Corporation | $56.73 | 2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Wavewriter Alpha Prime 16 |
| Supernus Pharmaceuticals, INC. | $55.17 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $54.15 | 2021-2023 | Onzetra Xsail |
| Janssen Biotech, INC. | $50.49 | 2025 | |
| C2n Diagnostics, LLC | $45.20 | 2025 | Precivityad2 |
| Arbor Pharmaceuticals, INC. | $44.42 | 2021 | |
| Impel Pharmaceuticals LLC | $40.40 | 2025 | Trudhesa |
| Mallinckrodt Hospital Products INC. | $39.61 | 2022 | |
| Banner Life Sciences, LLC | $38.30 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $34.26 | 2022 | |
| Axsome Therapeutics, INC. | $26.27 | 2025 | Symbravo |
| Microtransponder, INC. | $25.10 | 2025 | |
| Livanova USA, INC. | $22.77 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Xeris Pharmaceuticals, INC. | $22.09 | 2024 | Keveyis |
| Kyowa Kirin, INC. | $21.41 | 2023 | Nourianz |
| Nevro Corp. | $16.50 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Centers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.